INTRASENSE SAS EO -05
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, a, oncological imaging platform that… Read more
INTRASENSE SAS EO -05 (I8S) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, INTRASENSE SAS EO -05 (I8S) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
INTRASENSE SAS EO -05 - Net Assets Trend (None–None)
This chart illustrates how INTRASENSE SAS EO -05's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INTRASENSE SAS EO -05 (None–None)
The table below shows the annual net assets of INTRASENSE SAS EO -05 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to INTRASENSE SAS EO -05's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
INTRASENSE SAS EO -05 Competitors by Market Cap
The table below lists competitors of INTRASENSE SAS EO -05 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xtrackers Physical Gold ETC USD
SW:XGLD
|
$4.65 Million |
|
Jupiter Gold Corporation
PINK:JUPGF
|
$4.65 Million |
|
MEGLIOQUESTO S.P.A.
F:7V60
|
$4.65 Million |
|
Monumental Energy Corp.
V:MNRG
|
$4.65 Million |
|
Spenda Ltd
AU:SPX
|
$4.65 Million |
|
More Return Public Company Limited
BK:MORE
|
$4.65 Million |
|
TCI GENE Inc.
TWO:6879
|
$4.65 Million |
|
Indofarma Tbk
JK:INAF
|
$4.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INTRASENSE SAS EO -05's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares INTRASENSE SAS EO -05's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently INTRASENSE SAS EO -05 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares INTRASENSE SAS EO -05's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INTRASENSE SAS EO -05 (I8S) | €- | N/A | N/A | $4.65 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |